Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05508906
Title Phase 1b Combo w/ Ribociclib and Alpelisib
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center RECRUITING Gilbert Arizona 85234 United States Details
University of California San Francisco Health RECRUITING San Francisco California 94158 United States Details
University of Colorado Cancer Center RECRUITING Aurora Colorado 80045 United States Details
Advent Health Hematology and Oncology RECRUITING Orlando Florida 32804 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Henry Ford Health RECRUITING Detroit Michigan 48126 United States Details
Regents of the University of Minnesota RECRUITING Minneapolis Minnesota 55455 United States Details
Washington University, School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Ichan School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Atrium Health Levine Cancer Institute RECRUITING Charlotte North Carolina 28204 United States Details
Henry-Joyce Cancer Clinic, The Vanderbilt Clinic RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Northwest Medical Specialties RECRUITING Tacoma Washington 98405 United States Details
Breast Cancer Research Center- Western Australia RECRUITING Nedlands Western Australia 6009 Australia Details
Macquarie Health RECRUITING New South Wales 2109 Australia Details
*Shaded cells indicate that there was no data available from for the field